Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3787PDF: 1596HTML: 497Figures . Eliassian: 225 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
733PDF: 466HTML: 6272 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4267PDF: 1191HTML: 2164Figure 1: 170 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1609PDF: 805HTML: 1238Figure 1: 177Figure 2: 192Figure 3: 187 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1606PDF: 982HTML: 199 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4536PDF: 1936HTML: 17801 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3249PDF: 1015HTML: 2031 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8030PDF: 4199HTML: 7503 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1582PDF: 851HTML: 1038Picture 1: 170 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1495PDF: 1234HTML: 510 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2774PDF: 1091HTML: 121 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1257PDF: 476HTML: 18609Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 209Figure 5: 181 -
LIVER IRON CONTENT IN INDIVIDUALS WITH LIVER IRON CONTENT IN INDIVIDUALS WITH Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS.: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS. Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA
101PDF: 37Suppl. Files: 6HTML: 0 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1706PDF: 1450HTML: 251 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4139PDF: 1665HTML: 1010 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3945PDF: 1114HTML: 460 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2581PDF: 972HTML: 15116 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1602PDF: 1297HTML: 150 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1865PDF: 841HTML: 1591 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3343PDF: 585HTML: 667 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1414PDF: 823HTML: 3123







